Pharmacy Board warns against sale, import of unregistered products
Health & Science
By
Betty Njeru
| Jan 18, 2025
Government registered drugs found at a pharmacy in Kayole estate, Nairobi. [File, Standard]
The Pharmacy and Poisons Board (PPB) has issued a stern warning to health stakeholders against trading, importing, or handling unregistered pharmaceutical products in Kenya.
In a statement on Saturday, January 18, the PPB specifically cautioned against products referencing the Indian Pharmacopeia (IP).
“All stakeholders are hereby directed to cease and desist from trading, importing, or handling any unregistered products and ensure that all pharmaceutical products in their possession are duly registered and approved by the Pharmacy and Poisons Board,” the statement read.
The Board warned that noncompliance with this directive would result in the revocation of licenses and the seizure of products.
READ MORE
Third cruise ship docks as Ruto pledges to grow tourist numbers
Macadamia traders clash over AFA's alleged bias
47 ships reroute to Suez Canal since Feb
UAE investor inks Sh104b deal to expand Galana Kulalu project
Troubled Uchumi's creditors to know fate of their billions
Why tourism is Kenya's best bet to accelerate economic growth
BAT to pay Sh50 dividend despite 19pc profit dip
Appetite for Kenya's 'green gold' spawns new crop of millionaires
Policy Statement promises nothing unusual in CS Mbadi's first Budget
UNGA President Yang backs Equity's plan to boost youth innovation
The Indian Pharmacopeia is a set of standards for drugs and medicines manufactured, sold, and consumed in India.
However, the PPB clarified that these standards are not recognised under Kenya’s drug registration requirements, rendering products citing the IP non-compliant.
The Board further said it is actively monitoring the market and will take action against anyone found violating the regulatory framework.